The proper use of acetaminophen.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3223888)

Published in Paediatr Child Health on November 01, 2011

Authors

Laura James1, Janice E Sullivan, Dean Roberts

Author Affiliations

1: Department of Pediatrics, University of Arkansas for Medical Sciences, Section of Clinical Pharmacology and Toxicology, Arkansas Children's Hospital, Little Rock, Arkansas;

Articles cited by this

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66

Acetylcysteine for acetaminophen poisoning. N Engl J Med (2008) 5.92

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23

Acute liver necrosis following overdose of paracetamol. Br Med J (1966) 4.75

Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology (2006) 3.85

Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45

Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem (2006) 3.23

Acetaminophen-induced hepatotoxicity. Drug Metab Dispos (2003) 3.22

Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci (2005) 3.12

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03

Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr (1998) 3.02

Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics (2006) 2.96

Acetaminophen poisoning and toxicity. Pediatrics (1975) 2.71

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62

Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology (2011) 2.61

Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54

2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med (2002) 2.47

Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos (2002) 2.34

Predicting concentrations in children presenting with acetaminophen overdose. J Pediatr (1999) 2.25

Fever and antipyretic use in children. Pediatrics (2011) 2.22

Acetaminophen: the 150 mg/kg myth. J Toxicol Clin Toxicol (2004) 2.17

Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos (2009) 1.95

Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol (1991) 1.57

A difficult balance--pain management, drug safety, and the FDA. N Engl J Med (2009) 1.57

Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51

Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther (1989) 1.28

Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol (2005) 1.24

Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study. Toxicol Sci (2010) 1.11

Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98

Therapeutic acetaminophen is not associated with liver injury in children: a systematic review. Pediatrics (2010) 0.98

Acetaminophen: a practical pharmacologic overview. Can Med Assoc J (1984) 0.97

Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health (2007) 0.95

Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology (2010) 0.95

Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev (1995) 0.94

Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.93

Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin. Am J Kidney Dis (1996) 0.85

Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv Exp Med Biol (1981) 0.82

Articles by these authors

Fever and antipyretic use in children. Pediatrics (2011) 2.22

Prevalence of adverse events in pediatric intensive care units in the United States. Pediatr Crit Care Med (2010) 1.81

Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. Clin Infect Dis (2012) 1.63

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections. Pediatr Infect Dis J (2011) 1.30

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants. Antimicrob Agents Chemother (2012) 1.23

Level of trainee and tracheal intubation outcomes. Pediatrics (2013) 1.14

Cytokines and toxicity in acetaminophen overdose. J Clin Pharmacol (2005) 1.13

Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur J Clin Pharmacol (2012) 1.06

Population pharmacokinetics of piperacillin using scavenged samples from preterm infants. Ther Drug Monit (2012) 1.04

Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy (2008) 0.96

Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children. Biomark Med (2014) 0.93

Pharmacokinetics, Safety and Tolerability of Single Dose Dalbavancin in Children 12-17 Years of Age. Pediatr Infect Dis J (2015) 0.90

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma. Cancer Immunol Immunother (2015) 0.90

Pretreatment with midazolam blunts the rise in intracranial pressure associated with ketamine sedation for lumbar puncture in children. Pediatr Crit Care Med (2013) 0.89

Omegaven for the treatment of parenteral nutrition associated liver disease: a case study. J Ky Med Assoc (2009) 0.87

Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support. J Pediatr Hematol Oncol (2007) 0.82

Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit. J Diabetes Sci Technol (2012) 0.82

Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension. Paediatr Drugs (2012) 0.81

Accuracy of the Spacelabs 90217 ambulatory blood pressure monitor in a pediatric population. Blood Press Monit (2015) 0.80

Death in a toddler following endosulfan ingestion. Clin Toxicol (Phila) (2009) 0.79

Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease. Dig Dis Sci (2010) 0.78

Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease. Clin Pharmacokinet (2011) 0.77

Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age. Clin Ther (2012) 0.77

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J (2017) 0.75

Goal-Directed Resuscitative Interventions During Pediatric Interfacility Transport. Crit Care Med (2015) 0.75

Isoniazid hepatotoxicity: progress in understanding the immunologic component. Hepatology (2014) 0.75

The Use of Recombinant Antithrombin III in Pediatric and Neonatal ECMO Patients. ASAIO J (2016) 0.75

Intermediate syndrome after exposure to chlorpyrifos in a 16-month-old girl. J Emerg Med (2003) 0.75

Relationship Between Adverse Tracheal Intubation Associated Events and PICU Outcomes. Pediatr Crit Care Med (2017) 0.75

Promoters and Barriers to Implementation of Tracheal Intubation Airway Safety Bundle: A Mixed-Method Analysis. Pediatr Crit Care Med (2017) 0.75

Favorable Protonation of the (μ-edt)[Fe(2)(PMe(3))(4)(CO)(2)(H-terminal)](+) Hydrogenase Model Complex Over Its Bridging μ-H Counterpart: A Spectroscopic and DFT Study. Eur J Inorg Chem (2011) 0.75